CB
CBD Life Sciences Inc.
CBDL · OTC
$0.00 -33.33% (-$0.00)
1M +100.00%
Market Cap $281.5K
P/E Ratio -
Div. Yield -
ROE 9.15%
Piotroski F-Score Weak
3/9Valuation
81 /100
Cheap P/S 2.86x
P/B 0.37x
P/E N/A
Growth
22 /100
Declining Rev. growth 15.03%
Book val. growth 17.46%
EPS growth N/A
Profitability
17 /100
Weak Gross margin 42.20%
FCF margin 141.53%
Net margin 49.76%
Quality
2 /100
Poor ROIC 13.26%
Asset turnover 0.12x
ROE 9.15%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 15.12x
Int. coverage N/A
Stability
30 /100
Unstable Beta -0.59x
Profitable years 0
Rev. volatility 19.84%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CBDL
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lisa Anne Nelson
Employees
3
Headquarters
Scottsdale